ADVANCED SOFT TISSUE SARCOMA
Clinical trials for ADVANCED SOFT TISSUE SARCOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOFT TISSUE SARCOMA trials appear
Sign up with your email to follow new studies for ADVANCED SOFT TISSUE SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test Two-Drug attack on Tough-to-Treat sarcomas
Disease control OngoingThis study is testing the safety and early effectiveness of a new two-drug combination (HDM201 and pazopanib) for adults with advanced soft tissue sarcoma that has a specific genetic profile (p53 wild-type). The first part finds the safest dose, and the second part looks for earl…
Matched conditions: ADVANCED SOFT TISSUE SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New Two-Drug attack on Tough-to-Treat sarcoma
Disease control OngoingThis study is testing whether adding a newer drug, lurbinectedin, to a standard chemotherapy (doxorubicin) works better for treating advanced soft-tissue sarcoma. The first part checks the safety and best dose of the combination. The second part directly compares the new combinat…
Matched conditions: ADVANCED SOFT TISSUE SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC